• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于基于结构的自动化药物设计的新型计算工具。

A novel computational tool for automated structure-based drug design.

作者信息

Böhm H J

机构信息

BASF AG, Central Research, Ludwigshafen, Germany.

出版信息

J Mol Recognit. 1993 Sep;6(3):131-7. doi: 10.1002/jmr.300060305.

DOI:10.1002/jmr.300060305
PMID:8060670
Abstract

The computer program LUDI for automated structure-based drug design is described. The program constructs possible new ligands for a given protein of known three-dimensional structure. This novel approach is based upon rules about energetically favourable non-bonded contact geometries between functional groups of the protein and the ligand which are derived from a statistical analysis of crystal packings of organic molecules. In a first step small fragments are docked into the protein binding site in such a way that hydrogen bonds and ionic interactions can be formed with the protein and hydrophobic pockets are filled with lipophilic groups of the ligand. The program can then append further fragments onto a previously positioned fragment or onto an already existing ligand (e.g., a lead structure that one seeks to improve). It is also possible to link several fragments together by bridge fragments to form a complete molecule. All putative ligands retrieved or constructed by LUDI are scored. We use a simple scoring function that was fitted to experimentally determined binding constants of protein-ligand complexes. LUDI is a very fast program with typical execution times of 1-5 min on a work station and is therefore suitable for interactive usage.

摘要

本文描述了用于基于结构的自动化药物设计的计算机程序LUDI。该程序为已知三维结构的给定蛋白质构建可能的新配体。这种新方法基于关于蛋白质和配体官能团之间能量上有利的非键接触几何结构的规则,这些规则源自对有机分子晶体堆积的统计分析。第一步,将小片段对接至蛋白质结合位点,使得可以与蛋白质形成氢键和离子相互作用,并且疏水口袋被配体的亲脂性基团填充。然后该程序可以将更多片段附加到先前定位的片段上或已有的配体上(例如,一个有待改进的先导结构)。也可以通过桥连片段将几个片段连接在一起以形成一个完整的分子。LUDI检索或构建的所有推定配体都要进行评分。我们使用一个简单的评分函数,该函数与通过实验确定的蛋白质 - 配体复合物的结合常数相拟合。LUDI是一个非常快速的程序,在工作站上的典型执行时间为1 - 5分钟,因此适合交互式使用。

相似文献

1
A novel computational tool for automated structure-based drug design.一种用于基于结构的自动化药物设计的新型计算工具。
J Mol Recognit. 1993 Sep;6(3):131-7. doi: 10.1002/jmr.300060305.
2
An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes.使用包含800个蛋白质-配体复合物的PDBbind精制集对14种评分函数进行的广泛测试。
J Chem Inf Comput Sci. 2004 Nov-Dec;44(6):2114-25. doi: 10.1021/ci049733j.
3
Ligand design package (Ludi--MSI) applied to known inhibitors of the HIV-1 protease. Test of performance.配体设计软件包(Ludi--MSI)应用于已知的HIV-1蛋白酶抑制剂。性能测试。
Acta Pol Pharm. 2000 Nov;57 Suppl:25-8.
4
A novel approach to local similarity of protein binding sites substantially improves computational drug design results.一种用于蛋白质结合位点局部相似性的新方法显著改善了计算药物设计结果。
Proteins. 2007 Nov 1;69(2):349-57. doi: 10.1002/prot.21487.
5
A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.当前对接和评分方法在药物相关系统上的详细比较。
Proteins. 2004 Aug 1;56(2):235-49. doi: 10.1002/prot.20088.
6
CONCERTS: dynamic connection of fragments as an approach to de novo ligand design.音乐会:片段的动态连接作为从头设计配体的一种方法。
J Med Chem. 1996 Apr 12;39(8):1651-63. doi: 10.1021/jm950792l.
7
Form follows function: shape analysis of protein cavities for receptor-based drug design.形式追随功能:用于基于受体的药物设计的蛋白质腔的形状分析。
Proteomics. 2009 Jan;9(2):451-9. doi: 10.1002/pmic.200800092.
8
A general and fast scoring function for protein-ligand interactions: a simplified potential approach.一种用于蛋白质-配体相互作用的通用快速评分函数:一种简化的势能方法。
J Med Chem. 1999 Mar 11;42(5):791-804. doi: 10.1021/jm980536j.
9
FLEXS: a method for fast flexible ligand superposition.FLEXS:一种快速灵活的配体叠合方法。
J Med Chem. 1998 Nov 5;41(23):4502-20. doi: 10.1021/jm981037l.
10
LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads.
J Comput Aided Mol Des. 1992 Dec;6(6):593-606. doi: 10.1007/BF00126217.

引用本文的文献

1
Integrated Molecular Modeling and Machine Learning for Drug Design.基于分子模拟的药物设计与机器学习的整合。
J Chem Theory Comput. 2023 Nov 14;19(21):7478-7495. doi: 10.1021/acs.jctc.3c00814. Epub 2023 Oct 26.
2
Machine Learning and Computational Chemistry for the Endocannabinoid System.机器学习和计算化学在内源性大麻素系统中的应用。
Methods Mol Biol. 2023;2576:477-493. doi: 10.1007/978-1-0716-2728-0_39.
3
Protein-Ligand Docking in the Machine-Learning Era.蛋白质-配体对接在机器学习时代。
Molecules. 2022 Jul 18;27(14):4568. doi: 10.3390/molecules27144568.
4
In Silico Peptide Ligation: Iterative Residue Docking and Linking as a New Approach to Predict Protein-Peptide Interactions.计算机模拟肽键合:迭代残基对接和连接作为预测蛋白-肽相互作用的新方法。
Molecules. 2019 Apr 5;24(7):1351. doi: 10.3390/molecules24071351.
5
Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.基于吡咯酮的金属蛋白酶 2 和 3 的抑制剂可能作为构象选择性抑制剂发挥作用。
Chem Biol Drug Des. 2011 Aug;78(2):191-8. doi: 10.1111/j.1747-0285.2011.01148.x. Epub 2011 Jun 20.
6
Potential drug-like inhibitors of Group 1 influenza neuraminidase identified through computer-aided drug design.通过计算机辅助药物设计发现的具有潜在成药性的 Group 1 流感神经氨酸酶抑制剂。
Comput Biol Chem. 2010 Apr;34(2):97-105. doi: 10.1016/j.compbiolchem.2010.03.005. Epub 2010 Apr 3.
7
CONFIRM: connecting fragments found in receptor molecules.确认:在受体分子中发现连接片段。
J Comput Aided Mol Des. 2008 Oct;22(10):761-72. doi: 10.1007/s10822-008-9221-8. Epub 2008 Jul 9.
8
The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA.基于药物衍生分子片段的从头设计模板概念及其在TAR RNA中的应用。
J Comput Aided Mol Des. 2008 Feb;22(2):59-68. doi: 10.1007/s10822-007-9157-4. Epub 2007 Dec 7.
9
Computer-aided design and activity prediction of leucine aminopeptidase inhibitors.亮氨酸氨肽酶抑制剂的计算机辅助设计与活性预测
J Comput Aided Mol Des. 2000 Aug;14(6):531-44. doi: 10.1023/a:1008189716955.